For instance, rasl11a mRNA is less abundant in some prostate cancers [38], ris/rasl12 tumor suppressor function in breast cancer is controversial [37], [62], and rerg expression inhibits tumor formation in nude mice and is decreased or lost in primary human breast tumors [39]. Here, RASL12 is linked to prostate carcinoma.